Endo Pharmaceuticals to Pay Nearly $200 Million for False Marketing
“Failing to adhere to the safety and marketing standards put in place by the FDA can cause enormous risk to patients,” says Christopher Paulos, an attorney with the Levin, Papantonio law firm who practices in the areas of product liability, bad drug and False Claims Act litigation. “But time after time companies continue to put their own gains, their profits, before the safety and well-being of patients and consumers.” Last Friday, the Department of Justice announced that the pharmaceutical health companies Endo Pharmaceuticals and Endo Health Solutions would pay $192.7 million in order to resolve both criminal and civil...
Read More